DRI Healthcare to Host Second Quarter 2025 Earnings Call and Webcast on August 14, 2025
DRI Healthcare Comments on FDA Approval and our Increased Investment in KalVista Pharmaceuticals' Ekterly® (sebetrals...
DRI Healthcare Announces Closing of Internalization Transaction
